Bulk Manufacturer of Controlled Substances Application: Curia Missouri Inc., 55985 [2024-14926]
Download as PDF
<![CDATA[
55985
Federal Register / Vol. 89, No. 130 / Monday, July 8, 2024 / Notices
about the changes, as required by 41
CFR 102–3.150(a).
Notice of Federal Advisory
Committee meeting; amended.
ACTION:
Dated: July 3, 2024.
Thomas V. Curtin, Jr.,
Executive Director, Joint Board for the
Enrollment of Actuaries.
This notice amends the
location of the partially closed meeting
of the Advisory Committee on Actuarial
Examinations previously announced in
the Federal Register of June 14, 2024.
SUMMARY:
[FR Doc. 2024–14991 Filed 7–5–24; 8:45 am]
BILLING CODE 4830–01–P
July 11, 2024, from 9 a.m. to 5
p.m., and July 12, 2024, from 9:30 a.m.
to 3 p.m.
DATES:
DEPARTMENT OF JUSTICE
FOR FURTHER INFORMATION CONTACT:
Elizabeth Van Osten, Designated Federal
Officer, Advisory Committee on
Actuarial Examinations, at (202) 312–
3648 or Elizabeth.jvanosten@irs.gov.
As
published in the Federal Register of
June 14, 2024 (89 FR 50634), the
meeting was to be held at the Internal
Revenue Service, 1111 Constitution
Avenue NW, Washington, DC 20224.
However, due to an unexpected
building closure precluding an inperson meeting, the meeting will be
held by teleconference instead. There
are no other changes to the meeting.
Because the circumstances necessitating
the change to the venue of the meeting
are beyond the control of the Joint Board
or the Enrollment of Actuaries, it is
unable to provide public notification
SUPPLEMENTARY INFORMATION:
Drug Enforcement Administration
[Docket No. DEA–1389]
Bulk Manufacturer of Controlled
Substances Application: Curia
Missouri Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Curia Missouri Inc. has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
SUMMARY:
the issuance of the proposed registration
on or before September 6, 2024. Such
persons may also file a written request
for a hearing on the application on or
before September 6, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on May 29, 2024, Curia
Missouri Inc., 2460 West Bennett Street,
Springfield, Missouri 65807–1229,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
Controlled substance
Drug code
Gamma Hydroxybutyric Acid .........................................................................................................................................
Amphetamine .................................................................................................................................................................
Lisdexamfetamine ..........................................................................................................................................................
Methylphenidate .............................................................................................................................................................
Phenylacetone ...............................................................................................................................................................
Tapentadol .....................................................................................................................................................................
The company plans to bulk
manufacture the listed controlled
substances for internal use
intermediates or for sale to its
customers. No other activities for these
drug codes are authorized for this
registration.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–14926 Filed 7–5–24; 8:45 am]
BILLING CODE P
khammond on DSKJM1Z7X2PROD with NOTICES
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1385]
Bulk Manufacturer of Controlled
Substances Application: S&B Pharma
LLC DBA Norac Pharma
Drug Enforcement
Administration, Justice.
AGENCY:
VerDate Sep<11>2014
16:22 Jul 05, 2024
Jkt 262001
ACTION:
Notice of application.
S&B Pharma LLC DBA Norac
Pharma has applied to be registered as
a bulk manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before September 6, 2024. Such
persons may also file a written request
for a hearing on the application on or
before September 6, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
SUMMARY:
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
2010
1100
1205
1724
8501
9780
Schedule
I
II
II
II
II
II
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
In
accordance with 21 CFR 1301.33(a), this
is notice that on April 30, 2024, S&B
Pharma LLC DBA Norac Pharma, 405
South Motor Avenue, Azusa, California
91702, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
E:\FR\FM\08JYN1.SGM
08JYN1
]]>Agencies
[Federal Register Volume 89, Number 130 (Monday, July 8, 2024)]
[Notices]
[Page 55985]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-14926]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1389]
Bulk Manufacturer of Controlled Substances Application: Curia
Missouri Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Curia Missouri Inc. has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
September 6, 2024. Such persons may also file a written request for a
hearing on the application on or before September 6, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on May 29, 2024, Curia Missouri Inc., 2460 West Bennett
Street, Springfield, Missouri 65807-1229, applied to be registered as a
bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid........... 2010 I
Amphetamine......................... 1100 II
Lisdexamfetamine.................... 1205 II
Methylphenidate..................... 1724 II
Phenylacetone....................... 8501 II
Tapentadol.......................... 9780 II
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for internal use intermediates or for sale to its customers.
No other activities for these drug codes are authorized for this
registration.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-14926 Filed 7-5-24; 8:45 am]
BILLING CODE P
